Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Phytochem Anal ; 23(4): 387-95, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22025447

RESUMEN

INTRODUCTION: The quality control of Magnoliae officinalis Cortex, a commonly used traditional Chinese medicine, is currently based on the assay of the two active compounds, honokiol and magnolol, by TLC or HPLC. OBJECTIVE: To compare ¹H-NMR-based metabolomics with the HPLC method for controlling the quality of Magnoliae officinalis Cortex. To identify the metabolites contributing to the differences between the samples and to discriminate different medicinal parts and geographic origins of these samples by ¹H-NMR-based metabolomics. METHODOLOGY: ¹H-NMR and several multivariate analysis techniques were applied to analyse the extracts of 18 batches of Magnoliae officinalis Cortex commercial samples, and the contents of honokiol and magnolol in these samples were determined by HPLC. The correlation analysis between the data from ¹H-NMR and HPLC was performed with the mixOmics software based on an unsupervised method. RESULTS: Honokiol and magnolol were the main compounds responsible for the discrimination of samples from different batches, thus proving that the choice of these two compounds as markers for quality assessment by HPLC is relevant. The two sources of Magnoliae officinalis Cortex recorded in the Chinese Pharmacopoeia, Magnolia officinalis and Magnolia officinalis var. biloba, could be differentiated from ¹H-NMR data, but the pattern recognition analysis by PLS-DA was unsuccessful in discriminating samples from various geographical origins. CONCLUSION: The combination of ¹H-NMR that gives a comprehensive profile of the metabolites and HPLC that targets two biomarkers is an efficient means for a better quality control of Magnoliae officinalis Cortex.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Espectroscopía de Resonancia Magnética/métodos , Magnolia/química , Metabolómica/métodos , Programas Informáticos , Compuestos de Bifenilo/química , China , Medicamentos Herbarios Chinos/análisis , Medicamentos Herbarios Chinos/química , Ecosistema , Lignanos/química , Metaboloma , Análisis Multivariante , Control de Calidad , Sensibilidad y Especificidad
2.
J Proteome Res ; 8(12): 5580-9, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19813770

RESUMEN

The plasma of patients with stable carotid atherosclerosis (n = 9), and healthy subjects (n = 10) have been fingerprinted with both GC-MS and (1)H NMR. Principal component analysis (PCA), partial least-squares-discriminant analysis (PLS-DA) and orthogonal partial least-squares-discriminant analysis (OPLS-DA) have been applied to the profiles from each technique both separately and in combination. These techniques complement each other and enable a clearer picture of the biological samples to be interpreted not only for classification purposes, but also more importantly to define the metabolic state of patients with carotid atherosclerosis. The results showed at least 24 metabolites that were significantly modified in the group of atherosclerotic patients by this nontargeted procedure. Most of the changes can be associated to alterations of the metabolism characteristics of insulin resistance that can be strongly related to the metabolic syndrome. In addition, correlations among variables accounting for the classification show amino acids as variables whose changes showed a high degree of correlation. GC-MS and (1)H NMR fingerprints can provide complementary information in the identification of altered metabolic pathways in patients with carotid atherosclerosis. Moreover, correlations among the results with both techniques, instead of a single study, can provide a deeper insight into the patient state.


Asunto(s)
Aterosclerosis/metabolismo , Metaboloma , Metabolómica/métodos , Aminoácidos/análisis , Estudios de Casos y Controles , Análisis Discriminante , Cromatografía de Gases y Espectrometría de Masas , Humanos , Resistencia a la Insulina , Espectroscopía de Resonancia Magnética , Síndrome Metabólico/metabolismo , Análisis de Componente Principal
3.
Bioorg Med Chem ; 17(15): 5396-407, 2009 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-19595598

RESUMEN

Ciprofloxacin (CP), an antibiotic has been shown to have antiproliferative and apoptotic activities in several cancer cell lines. Moreover, several reports have highlighted the interest of increasing the lipophilicity to improve the antitumor efficacy. These studies have led us to synthesize new CP derivatives of various lipophilicities and to evaluate their activity in five human cancer cell lines. With an easy and cost-efficient procedure, 31 7-((4-substituted)piperazin-1-yl) derivatives of CP were prepared that displayed IC(50) values ranging from microM to mM concentrations and are non-toxic in vivo in healthy mice as shown by their maximal tolerated dose (MTD) indices >80 mg/kg. Several derivatives displayed higher in vitro antitumor activity than parent CP however this was not dependent on the lipophilicity of the substituent. Among all synthesized derivatives, the most potent were 2 and 6h whose IC(50) values were 10 microM in three (derivative 2) or four (derivative 6h) cancer cell lines.


Asunto(s)
Antineoplásicos/química , Antineoplásicos/farmacología , Ciprofloxacina/análogos & derivados , Ciprofloxacina/farmacología , Piperazinas/química , Piperazinas/farmacología , Animales , Antineoplásicos/toxicidad , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Ciprofloxacina/síntesis química , Ciprofloxacina/toxicidad , Humanos , Dosis Máxima Tolerada , Ratones , Neoplasias/tratamiento farmacológico , Piperazina , Piperazinas/síntesis química , Piperazinas/toxicidad
4.
J Pharm Biomed Anal ; 59: 58-66, 2012 Feb 05.
Artículo en Inglés | MEDLINE | ID: mdl-22030075

RESUMEN

iErect, a new dietary supplement marketed as "100% natural" and sold over the Internet, was analyzed. It contains thiosildenafil, a sildenafil analogue already reported as an adulterant in herbal formulations, and a new compound whose structure was elucidated after isolation using NMR, MS and IR. It was named depiperazinothiosildenafil as it results from the hydrolytic cleavage of the S-N bond of the sulfonamide group of thiosildenafil. A capsule of iErect contains a very high amount (≈220mg) of thiosildenafil and ≈30mg of depiperazinothiosildenafil, which places consumers at risk for potentially serious side-effects.


Asunto(s)
Suplementos Dietéticos/análisis , Suplementos Dietéticos/normas , Contaminación de Medicamentos , Piperazinas/aislamiento & purificación , Preparaciones de Plantas/análisis , Preparaciones de Plantas/normas , Pirimidinas/aislamiento & purificación , Sulfonas/aislamiento & purificación , Tionas/aislamiento & purificación , Cápsulas , Cromatografía Líquida de Alta Presión , Contaminación de Medicamentos/legislación & jurisprudencia , Espectroscopía de Resonancia Magnética , Piperazinas/química , Purinas/química , Purinas/aislamiento & purificación , Pirimidinas/química , Citrato de Sildenafil , Espectroscopía Infrarroja por Transformada de Fourier , Sulfonas/química , Espectrometría de Masas en Tándem , Tionas/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA